1
|
Tse YK, Ren QW, Wu MZ, Huang JY, Leung CKL, Li HL, Yiu KH. Statin use after valvular heart surgery is associated with a decreased risk of prosthetic valve endocarditis. Eur Heart J 2023. [DOI: 10.1093/eurheartj/ehac779.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public hospital(s). Main funding source(s): Sanming Project of Medicine in Shenzhen, China;
HKU-SZH Fund for Shenzhen Key Medical Discipline
Background
Prosthetic valve endocarditis (PVE) is a rare but serious complication following valvular heart surgery for which preventive strategies remain unknown. Recent epidemiological evidence suggests that statins may reduce the risk of infections and infection-related complications.
Purpose
We aim to assess the association between statin use and the risk of prosthetic valve endocarditis in patients undergoing valvular heart surgery.
Methods
In all patients undergoing valvular heart surgery in Hong Kong between 2010 and 2021, statin use was ascertained by ≥14-day consecutive filled prescriptions after surgery. Stepwise Poisson regression was applied to identify predictors of PVE. Baseline characteristics between statin nonusers (N = 1400) with statin users (N = 976) were balanced using the inverse probability of treatment weighting. Cox proportional-hazard models with competing risk regression were further performed to estimate the risk of PVE and cardiovascular mortality associated with statin use.
Results
Our study included 2376 patients; the mean age was 57.8±14.2 years, and 54.4% were males. Over a median follow-up of 5.5 years (interquartile range 2.8-8.6), PVE occurred in 93 patients (6.75 [95% CI 5.51-8.26] PVE events per 1000 person-years). PVE was associated with New York Heart Association Class (Relative Risk [RR] 1.22, 95% Confidence Interval [CI] 1.01-1.45; P = 0.035), prior infective endocarditis (RR 8.64, 95% CI 5.58-13.19; P < 0.001), and aortic valve replacement (RR 1.67, 95% CI 1.11-2.53; P = 0.014).
Compared with non-use, statin use was associated with a 47% lower risk of PVE incidence (multivariable-adjusted subdistribution hazard ratio [SHR] 0.53, 95% CI 0.33-0.83; P = 0.006) (Figure 1). This inverse association with the risk of PVE was duration dependent, with an adjusted SHR of 0.60 (95% CI 0.47-0.73; P < 0.001) per year of statin use. Results were consistent across subgroups of sex (male vs female), the number of valvular procedures (single vs multiple), and prosthesis type (mechanical vs biological), but not in groups aged ≤60 years or with prior infective endocarditis (Figure 2). Statin use was associated with a 45% decreased risk of cardiovascular death (SHR 0.55, 95% CI 0.36-0.84; P = 0.006).
Conclusions
In patients undergoing valvular surgery, post-operative statin use is associated with a lower risk of PVE. These results provide new avenues for preventing PVE and hence valve failure.
Collapse
Affiliation(s)
- Y K Tse
- The University of Hong Kong , Hong Kong , Hong Kong
| | - Q W Ren
- The University of Hong Kong , Hong Kong , Hong Kong
| | - M Z Wu
- The University of Hong Kong , Hong Kong , Hong Kong
| | - J Y Huang
- The University of Hong Kong , Hong Kong , Hong Kong
| | - C K L Leung
- The University of Hong Kong , Hong Kong , Hong Kong
| | - H L Li
- The University of Hong Kong , Hong Kong , Hong Kong
| | - K H Yiu
- The University of Hong Kong , Hong Kong , Hong Kong
| |
Collapse
|
2
|
Tsui L, Yiu KH, Tse HF, Lam LY, Leung CKL, Yu ASY, Wu MZ, Ren QW, Wong PF, Tse YK, Yu SSY, Li HL, Hon WL. Prognostic value of pre-operative left atrial strain on composite endpoint in patients received aortic valve replacement for severe aortic stenosis: a retrospective cohort study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehab849.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Objective
Severe aortic stenosis (AS) is the most common primary valvular heart disease, treatable only by aortic valve replacement (AVR). Current literatures have shown that severe AS may precede atrial dysfunction which predicts adverse outcomes. However, predictive value of pre-operative left atrial (LA) function on post-AVR clinical outcomes is uncertain. The study aims to evaluate the prognostic value of pre-operative LA strain on post AVR all-cause mortality and heart failure.
Methods
Patients aged 18 years old or above with severe AS were recruited and assessed using speckle-tracking echocardiography pre-operatively. Severe AS was defined according to 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Peak Atrial Longitudinal Strain (PALS) was measured as a surrogate of LA function. Patients with underlying pre-operative atrial fibrillation and other severe valvular heart diseases were excluded. High PALS was defined as PALS higher than 15.94%. Patients were followed up until death or end of the study. The primary endpoint is a composite endpoint of all-cause mortality and heart failure during hospitalisation. The association of LA function with composite endpoint of all-cause mortality and heart failure was evaluated by Cox Proportional Hazards analysis.
Results
A total of 128 patients (mean age 65.3.9 ± 9.4 years, 56.3% male) were analysed. Patients were followed up for a mean period of 3.9 ± 2.4years. A total of 65 of 128 patients (50.8%) belonged to low PALS group. During the study period, 23 patients developed events on the composite endpoint. Among those with composite endpoint, low PALS group accounted for 18 (78.3%) patients and high PALS group accounted for 5 (21.7%) patients. Higher PALS was independently associated with lower risk of composite endpoint of all-cause mortality and heart failure (HR, 0.33; 95% CI 0.117-0.916, p = 0.03) after adjustment for EuroSCORE II.
Conclusion
Higher PALS, a surrogate of LA function, is associated with a lower risk of composite endpoints of mortality and heart failure in patients with severe AS undergoing AVR, independent of EuroSCORE II. Evaluation of LA function by assessing speckle tracking derived PALS may aid in prognostication for patients undergoing AVR.
Collapse
Affiliation(s)
- L Tsui
- The University of Hong Kong, Hong Kong, Hong Kong
| | - K H Yiu
- The University of Hong Kong, Hong Kong, Hong Kong
| | - H F Tse
- The University of Hong Kong, Hong Kong, Hong Kong
| | - L Y Lam
- The University of Hong Kong, Hong Kong, Hong Kong
| | - C K L Leung
- The University of Hong Kong, Hong Kong, Hong Kong
| | - A S Y Yu
- The University of Hong Kong, Hong Kong, Hong Kong
| | - M Z Wu
- The University of Hong Kong, Hong Kong, Hong Kong
| | - Q W Ren
- The University of Hong Kong, Hong Kong, Hong Kong
| | - P F Wong
- The University of Hong Kong, Hong Kong, Hong Kong
| | - Y K Tse
- The University of Hong Kong, Hong Kong, Hong Kong
| | - S S Y Yu
- The University of Hong Kong, Hong Kong, Hong Kong
| | - H L Li
- The University of Hong Kong, Hong Kong, Hong Kong
| | - W L Hon
- The University of Hong Kong, Hong Kong, Hong Kong
| |
Collapse
|
3
|
Li KY, Lam LY, Leung CKL, Yu ASY, Wu MZ, Ren QW, Wong PF, Tse YK, Yu SSY, Li HL, Feng Y, Huo Y, Yiu KH. Prognostic value of a novel index: computational pressure-flow dynamics derived fractional flow reserve in patients with stable coronary artery disease treated with optimal medical therapy alone. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The use of fractional flow reserve (FFR) is limited due to the need of invasive pressure wire and hyperaemic stimulus. Computational pressure-flow dynamics derived fractional flow reserve (caFFR) is a novel non-invasive index to determine the FFR in patients with stable coronary artery disease (CAD).
Purpose
The clinical value of caFFR remains uncertain. The aim of the study is to evaluate the prognostic role of caFFR in patients with stable CAD who were treated by optimal medical therapy alone.
Methods
A total of 558 stable CAD patients (mean age=64.5±11.2, 59.0% male) with ≥1 coronary lesion detected during conventional coronary angiogram were included. All of them did not undergo percutaneous coronary intervention and were treated with optimal medical therapy alone. Patients were then classified into 4 groups according to their caFFR value; caFFR ≤0.70 (n=40), caFFR = 0.71–0.80 (n=28), caFFR = 0.81–0.90 (n=292), caFFR = 0.91–1.00 (n=198), with a lower caFFR indicating a greater magnitude of myocardial ischemia. The primary endpoint was 3-year major adverse cardiac events (MACE), defined as a composite of all-cause mortality, myocardial infarction or any unplanned revascularization.
Results
During a median follow-up of 36 months, a total of 49 composite events occurred, including 27 all-cause mortality, 4 myocardial infarction and 18 unplanned revascularization.
After multivariate adjustment, caFFR was an independent predictor of MACE (adjusted hazard ratio [HR] = 0.97 per 0.01 increase in caFFR; 95% confidence interval [Cl], 0.95–0.99; P<0.01), all-cause mortality (adjusted HR = 0.96 per 0.01 increase in caFFR; 95% Cl, 0.94–0.99; P<0.01), and stroke (adjusted HR = 0.95 per 0.01 increase in caFFR; 95% Cl, 0.90–0.99; P=0.03).
The area under the curve (AUC) by receiver-operating characteristic curve analysis (ROC) is 0.70 (95% Cl, 0.62–0.78; P<0.01). The optimal cut-off of caFFR defined by ROC analysis for predicting MACE is 0.80, concluding that patients with caFFR ≤0.80 have significantly higher adverse event rate, which is consistent with the cut-off from wire-based FFR.
Using caFFR = 0.91–1.00 as reference, the risk of MACE was highest in patients with caFFR ≤0.70 (adjusted HR = 4.65; 95% Cl, 1.81–11.94; P<0.01), followed by caFFR = 0.71–0.80 (adjusted HR = 3.67; 95% Cl, 1.12–11.33; P=0.02). The risk of MACE was nonetheless similar among patients with caFFR >0.8 (adjusted HR = 1.39; 95% Cl, 0.61–3.19, P=0.44).
Conclusion
In patients with stable CAD who were treated with optimal medical therapy alone, those with more significant myocardial ischemia, indicated by lower caFFR, had higher risks of adverse outcomes. The finding thus supports the use of this non invasive index to quantify the severity of myocardial ischemia, improve risk-stratification, and predict adverse outcomes in patients with stable CAD.
Funding Acknowledgement
Type of funding sources: Public hospital(s). Main funding source(s): The University of Hong Kong, Queen Mary Hospital
Collapse
Affiliation(s)
- K Y Li
- The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China
| | - L Y Lam
- The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China
| | - C K L Leung
- The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China
| | - A S Y Yu
- Queen Mary Hospital, The University of Hong Kong, Department of Medicine, Hong Kong, Hong Kong
| | - M Z Wu
- Queen Mary Hospital, The University of Hong Kong, Department of Medicine, Hong Kong, Hong Kong
| | - Q W Ren
- Queen Mary Hospital, The University of Hong Kong, Department of Medicine, Hong Kong, Hong Kong
| | - P F Wong
- Queen Mary Hospital, The University of Hong Kong, Department of Medicine, Hong Kong, Hong Kong
| | - Y K Tse
- The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China
| | - S S Y Yu
- The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China
| | - H L Li
- The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China
| | - Y Feng
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - Y Huo
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - K H Yiu
- Queen Mary Hospital, The University of Hong Kong, Department of Medicine, Hong Kong, Hong Kong
| |
Collapse
|
4
|
Lam LY, Leung CKL, Li KY, Wu MZ, Ren QW, Li HL, Yu SSY, Tse YK, Yu ASY, Wong PF, Tse HF, Feng Y, Huo Y, Yiu KH. Association between non-wire based computational angiography fractional flow reserve treatment threshold and major adverse cardiac events in patients with stable coronary artery disease. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Despite class IA guideline recommendations, the use of fractional flow reserve (FFR) in guiding percutaneous coronary intervention (PCI) in stable coronary artery disease (CAD) patients remains low due to limitations including the need of guidewire placement and hyperaemic stimulus. A novel non-invasive index, computational pressure-flow dynamics derived FFR (caFFR), was developed for measuring functional myocardial ischemia and overcoming the limitations of FFR. However, the clinical relevance of caFFR remains to be investigated. In the present study, we aim at evaluating the prognostic value of caFFR among stable CAD patients.
Methods
We retrospectively included patients with stable CAD who underwent coronary angiography during 2014–2016 at our center. Based on the caFFR value, patients were considered to be ischemic (caFFR ≤0.8) and non-ischemic (caFFR >0.8). Further, we recombined the patients to form the adherence cohort, where patients were defined as adherent-to-caFFR if they were ischemic with PCI or non-ischemic without PCI, and nonadherent-to-caFFR if they were ischemic without PCI or non-ischemic with PCI. The primary endpoint was major adverse cardiac events (MACE), defined as a composite of all-cause mortality, non-fatal myocardial infarction, and any revascularization. Inverse probability of treatment weighting was used to account for treatment selection bias (PCI vs without PCI, or adherent vs non-adherent), and Cox proportional hazard model was used to evaluate the association with MACE.
Results
A total of 1322 patients, 782 patients in the ischemic cohort and 540 patients in the non-ischemic cohort respectively, were included in our analysis. PCI was associated with a lower risk of MACE in the ischemic cohort (hazard ratio [HR] 0.52; 95% confidence interval [CI], 0.34–0.80; P=0.002), but was not associated with MACE in the non-ischemic cohort. In the adherence cohort, adherent-to-caFFR group (n=803) had a lower risk of MACE compared with nonadherent-to-caFFR group (n=566) (HR, 0.61; 95% CI, 0.44–0.85; P=0.003).
Conclusion
Our study is the first to demonstrate the prognostic value of caFFR, a non-wire based assessment of myocardial ischemia, in patients with stable CAD undergoing PCI. These findings support the use of caFFR that bears the potential of a wider adoption compared with wire-based FFR through a reduction in procedure time, risk and costs.
Funding Acknowledgement
Type of funding sources: None. Weighted Kaplan-Meier curvesWeighted Cox proportional hazards model
Collapse
Affiliation(s)
- L Y Lam
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - C K L Leung
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - K Y Li
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - M Z Wu
- The University of Hong Kong Shenzhen Hospital, Department of Medicine, Shenzhen, China
| | - Q W Ren
- The University of Hong Kong Shenzhen Hospital, Department of Medicine, Shenzhen, China
| | - H L Li
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - S S Y Yu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - Y K Tse
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - A S Y Yu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - P F Wong
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - H F Tse
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - Y Feng
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - Y Huo
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - K H Yiu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| |
Collapse
|
5
|
Leung CKL, Lam LY, Li KY, Yu ASY, Wu MZ, Ren QW, Wong PF, Tse YK, Yu SSY, Li HL, Feng Y, Huo Y, Tse HF, Yiu KH. Prognostic value of per-vessel treatment adherence in stable coronary artery disease based on novel computational pressure-flow dynamics derived fractional flow reserve. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Computational pressure-flow dynamics derived fractional flow reserve (caFFR) is a novel index developed to evaluate the extent of myocardial ischemia in patients with coronary artery disease (CAD), which eliminates the need of invasive pressure guidewire and hyperaemic stimulus in conventional fractional flow reserve (FFR) measurement. Studies have shown improved clinical outcomes associated with adherence to functional myocardial ischemia assessment when deciding to perform percutaneous coronary intervention (PCI) at a per-patient level. However, the clinical significance of such treatment adherence at a per-vessel level remains uncertain.
Methods
A total of 928 patients (mean age 66.2±10.5, male 72.7%) with stable CAD were included in this study. The caFFR of all three major coronary vessels were obtained for every patient, and the FFR threshold of 0.8 was adopted as the threshold for caFFR to indicate functionally significant artery stenosis which warrants PCI, and vice versa. Based on the caFFR of each major coronary vessel and whether PCI was performed to the respective vessel, patients were stratified into 0–1 vessel with treatment adherence group (group 1) (n=105), 2 vessels with treatment adherence group (group 2) (n=338), and 3 vessels with treatment adherence group (group 3) (n=485). The primary endpoint was major adverse cardiac events (MACE), defined as a composite of all-cause mortality, non-fatal myocardial infarction and any subsequent revascularization.
Results
The severity of CAD based on SYNTAX score assessment was 18.6±10.2 in group 1, 14.6±8.9 in group 2, and 11.5±9.9 in group 3 (P<0.001). The rates of MACE at 3 years were significantly different across groups 1, 2 and 3 (17.1% vs. 12.1% vs. 7.4%; P=0.004). With reference to group 3, the risk of MACE at 3 years was increased in group 2 (adjusted hazard ratio [HR]=1.597; 95% confidence interval [CI]=1.020–2.501; P=0.041), and further increased in group 1 (adjusted HR=1.933; 95% CI=1.081–3.457; P=0.026).
Conclusion
In stable CAD patients, the risk of MACE is incremental when fewer major coronary vessels are treated with adherence to caFFR threshold of 0.8. Per-vessel treatment adherence significantly affects clinical outcomes in terms of MACE.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C K L Leung
- The University of Hong Kong, Hong Kong, Hong Kong
| | - L Y Lam
- The University of Hong Kong, Hong Kong, Hong Kong
| | - K Y Li
- The University of Hong Kong, Hong Kong, Hong Kong
| | - A S Y Yu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - M Z Wu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - Q W Ren
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - P F Wong
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - Y K Tse
- The University of Hong Kong, Hong Kong, Hong Kong
| | - S S Y Yu
- The University of Hong Kong, Hong Kong, Hong Kong
| | - H L Li
- The University of Hong Kong, Hong Kong, Hong Kong
| | - Y Feng
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - Y Huo
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - H F Tse
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - K H Yiu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| |
Collapse
|
6
|
Lam LY, Leung CKL, Li KY, Li HL, Wu MZ, Ren QW, Yu ASY, Wong PF, Tse YK, Yu SSY, Feng Y, Huo Y, Tse HF, Yiu KH. Long-term prognostic implications of PCI in ACS patients without ischemia on the basis of computational pressure-flow dynamics derived fractional flow reserve. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
A substantial proportion of patients with acute coronary syndrome (ACS) may have intermediate lesion that are non-ischemic during emergency coronary angiography. The prognosis of such patients, compared to those with stable ischemic heart disease (SIHD) without ischemic lesion is however uncertain. Recently, a novel index, computational pressure-flow dynamics derived fractional flow reserve (caFFR), has been developed to assess myocardial ischemia, without the need of invasive pressure wire and hyperaemic stimulus as required in conventional fractional flow reserve (FFR). By utilizing caFFR to assess for ischaemic status during coronary angiography, the aim of our study is first to assess the prognostic difference between ACS and SIHD with non-ischaemia intermediate lesions. Second, we ascertain whether PCI in patients with ACS with non-ischaemia intermediate lesions provides survival benefit in addition to medical therapy.
Methods
We retrospectively recruited 551 patients (mean age 64.4 years; male 59.9%) with absence of myocardial ischaemia, defined as caFFR ≥0.80 in all vessels, from our Hospital. Patients were stratified into those with index presentation of ACS (n=132) and those with SIHD (n=491). Among the ACS cohort, patients were further divided into those with PCI (n=83) and with medical therapy alone (n=49). The SIHD cohort (n=491), all of whom were treated with medical therapy alone, was considered as referent group. The primary end point was major adverse cardiovascular events (MACE) at 3 years, which was defined as a composite of all-cause mortality, non-fatal myocardial infarction (MI), and any unplanned revascularization.
Results
During a median follow-up of 36 months, 54 composite events occurred, including 38 all-cause mortality, 5 MI, and 14 unplanned revascularization. Compared to those with SIHD, patients with ACS was independently associated with MACE even in the absence of myocardial ischaemia (adjusted Hazard Ratios=2.531; 95% confidence interval=1.397–4.586; P=0.002). The 3-year incidence rate of MACE was the highest in ACS patients with medical therapy alone, followed by ACS patients with immediate PCI; the SIHD cohort had the lowest incidence rates (30.6% vs 12.0% vs 5.9%, P<0.001). This was mainly driven by the rate of all-cause death (26.5% vs 12.0% vs 3.1%; P<0.001). Similar findings were observed for hospitalisation due to heart failure (14.3% vs 6.0% vs 3.1%, P=0.031) and cardiac death (8.2% vs 4.8% vs 0.4%, P<0.001) at 3 years.
Conclusion
In patients with intermediate lesion without myocardial ischaemia (defined as caFFR ≥0.8), those presented with ACS had a higher risk of MACE at 3 years compared to SIHD. Among ACS patients with intermediate lesion without myocardial ischaemia, PCI significantly reduces the rate of MACE. In patients with ACS, our finding suggests that PCI should be advocated to intermediate lesion even without myocardial ischaemia.
Funding Acknowledgement
Type of funding sources: None. Kaplan-Meier curve for MACECumulative Events at 3 Years
Collapse
Affiliation(s)
- L Y Lam
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - C K L Leung
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - K Y Li
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - H L Li
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - M Z Wu
- The University of Hong Kong Shenzhen Hospital, Department of Medicine, Shenzhen, China
| | - Q W Ren
- The University of Hong Kong Shenzhen Hospital, Department of Medicine, Shenzhen, China
| | - A S Y Yu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - P F Wong
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - Y K Tse
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - S S Y Yu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - Y Feng
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - Y Huo
- PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China
| | - H F Tse
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| | - K H Yiu
- Queen Mary Hospital, Department of Medicine, Hong Kong, Hong Kong
| |
Collapse
|